These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9154878)

  • 1. Dose-related reversal of acute lung rejection by aerosolized cyclosporine.
    Iacono AT; Smaldone GC; Keenan RJ; Diot P; Dauber JH; Zeevi A; Burckart GJ; Griffith BP
    Am J Respir Crit Care Med; 1997 May; 155(5):1690-8. PubMed ID: 9154878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of refractory acute allograft rejection with aerosolized cyclosporine in lung transplant recipients.
    Keenan RJ; Iacono A; Dauber JH; Zeevi A; Yousem SA; Ohori NP; Burckart GJ; Kawai A; Smaldone GC; Griffith BP
    J Thorac Cardiovasc Surg; 1997 Feb; 113(2):335-40; discussion 340-1. PubMed ID: 9040628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerosolized cyclosporine in lung recipients with refractory chronic rejection.
    Iacono AT; Keenan RJ; Duncan SR; Smaldone GC; Dauber JH; Paradis IL; Ohori NP; Grgurich WF; Burckart GJ; Zeevi A; Delgado E; O'Riordan TG; Zendarsky MM; Yousem SA; Griffith BP
    Am J Respir Crit Care Med; 1996 Apr; 153(4 Pt 1):1451-5. PubMed ID: 8616581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebulized cyclosporine for prevention of acute pulmonary allograft rejection in the rat: pharmacokinetic and histologic study.
    Blot F; Tavakoli R; Sellam S; Epardeau B; Faurisson F; Bernard N; Becquemin MH; Frachon I; Stern M; Pocidalo JJ
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1162-72. PubMed ID: 8719464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of inhaled cyclosporine in lung transplant recipients with refractory rejection: correlation of intragraft cytokine gene expression with pulmonary function and histologic characteristics.
    Keenan RJ; Zeevi A; Iacono AT; Spichty KJ; Cai JZ; Yousem SA; Ohori NP; Paradis IL; Kawai A; Griffith BP
    Surgery; 1995 Aug; 118(2):385-91. PubMed ID: 7638755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerosol cyclosporine prevents acute allograft rejection in experimental lung transplantation.
    Mitruka SN; Pham SM; Zeevi A; Li S; Cai J; Burckart GJ; Yousem SA; Keenan RJ; Griffith BP
    J Thorac Cardiovasc Surg; 1998 Jan; 115(1):28-36; discussion 36-7. PubMed ID: 9451042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 6 and interferon-gamma gene expression in lung transplant recipients with refractory acute cellular rejection: implications for monitoring and inhibition by treatment with aerosolized cyclosporine.
    Iacono A; Dauber J; Keenan R; Spichty K; Cai J; Grgurich W; Burckart G; Smaldone G; Pham S; Ohori NP; Yousem S; Williams P; Griffith B; Zeevi A
    Transplantation; 1997 Jul; 64(2):263-9. PubMed ID: 9256185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.
    Sarahrudi K; Estenne M; Corris P; Niedermayer J; Knoop C; Glanville A; Chaparro C; Verleden G; Gerbase MW; Venuta F; Böttcher H; Aubert JD; Levvey B; Reichenspurner H; Auterith A; Klepetko W
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1126-32. PubMed ID: 15052212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of inhaled cyclosporine in lung-transplant recipients.
    Iacono AT; Johnson BA; Grgurich WF; Youssef JG; Corcoran TE; Seiler DA; Dauber JH; Smaldone GC; Zeevi A; Yousem SA; Fung JJ; Burckart GJ; McCurry KR; Griffith BP
    N Engl J Med; 2006 Jan; 354(2):141-50. PubMed ID: 16407509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac allograft rejection: do trough cyclosporine levels correlate with the grade of histologic rejection?
    el Gamel A; Keevil B; Rahman A; Campbell C; Deiraniya A; Yonan N
    J Heart Lung Transplant; 1997 Mar; 16(3):268-74. PubMed ID: 9087869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus therapy for persistent or recurrent acute rejection after lung transplantation.
    Horning NR; Lynch JP; Sundaresan SR; Patterson GA; Trulock EP
    J Heart Lung Transplant; 1998 Aug; 17(8):761-7. PubMed ID: 9730424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
    Greig P; Lilly L; Scudamore C; Erb S; Yoshida E; Kneteman N; Bain V; Ghent C; Marotta P; Grant D; Wall W; Tchervenkov J; Barkun J; Roy A; Marleau D; McAlister V; Peltekian K
    Liver Transpl; 2003 Jun; 9(6):587-95. PubMed ID: 12783400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Refractoriness" of airflow obstruction associated with isolated lymphocytic bronchiolitis/bronchitis in pulmonary allografts.
    Ross DJ; Marchevsky A; Kramer M; Kass RM
    J Heart Lung Transplant; 1997 Aug; 16(8):832-8. PubMed ID: 9286775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase III prospective, randomized study to evaluate concentration-controlled sirolimus (rapamune) with cyclosporine dose minimization or elimination at six months in de novo renal allograft recipients.
    Baboolal K
    Transplantation; 2003 Apr; 75(8):1404-8. PubMed ID: 12717239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
    Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
    J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery and distribution of aerosolized cyclosporine in lung allograft recipients.
    O'Riordan TG; Iacono A; Keenan RJ; Duncan SR; Burckart GJ; Griffith BP; Smaldone GC
    Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):516-21. PubMed ID: 7842214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial.
    Gullestad L; Iversen M; Mortensen SA; Eiskjaer H; Riise GC; Mared L; Bjørtuft O; Ekmehag B; Jansson K; Simonsen S; Gude E; Rundqvist B; Fagertun HE; Solbu D; Bergh CH
    Transplantation; 2010 Apr; 89(7):864-72. PubMed ID: 20061999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.